Overview

Webcast ImageWebcast
ChromaDex Q2 2017 Conference Call  (Replay)
08/10/17 at 1:30 p.m. PT
ChromaDex Q2 2017 Conference Call
Thursday, August 10, 2017 1:30 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Where the power of nature meets the logic of science for the betterment of health.
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property.... More »

Stock Quote
NASDAQ - CDXC
Price$3.18
Change (%) Stock is Up 0.01 (0.32%)
Volume116,097
Refresh quote
Real-Time Level 2 Quote
Recent NewsMore »
DateTitle 
08/10/17ChromaDex Reports Second Quarter 2017 Financial Results
-Company Reports Revenue of $5.3 Million for Q2 2017- - Continued Progress on Building a Consumer Products Platform Around TruNiagen®- IRVINE, Calif., Aug. 10, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today the financial results for the quarter ended July 1,... 
Printer Friendly Version
08/03/17ChromaDex® to Report Second Quarter 2017 Financial Results on Thursday, August 10, 2017
Company Will Host Investor Conference Call on Thursday, August 10, 2017 IRVINE, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that it plans on reporting its second quarter 2017 financial results on Thursday, August 10, after the close of the ... 
Printer Friendly Version
07/10/17ChromaDex Sponsors Global Gathering of Scientific Leaders in NAD+ Metabolism and Signaling at the 2017 Federation of American Societies for Experimental Biology Conference
Findings from the University of Colorado Boulder Nicotinamide Riboside Human Clinical Trial, to be Presented to the Scientific Community IRVINE, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness, and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products announced today it is a proud sponsor of the Federation of American ... 
Printer Friendly Version
Upcoming EventsMore »

There are currently no events scheduled.

What's New
Download Documentation2017 Q2 Quarterly Report on Form 10Q
Download DocumentationSpecial Meeting – Proxy Statement
Download Documentation2017 Proxy Statement
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Chromadex Corp posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.